第6回 日経アジア・アフリカ感染症会議2019 あらたな産官学連携による日本発のイニシアチブ - The 6th Nikkei Asian Africa Conference on Communicable Diseases 2019 Japan’s New Initiative through Public-Private Partnership

開催日 2019年8月31日(土)・9月1日(日)参加料無料 事前登録抽選制 dates August 31 (Sat.) - September 1 (Sun.) 2019 FREE Admission Pre-registration/Selection
Statement - ステートメント
第6回日経アジア・アフリカ感染症会議
「横浜感染症ステートメント 2019」

Program - プログラム

DAY1August 31(SAT.) 8月31日(土)

* Please note that program details may be subject to change.
* Simultaneous interpretation is available at this conference.

8:30 -

Doors open開場

9:00 - 9:08

Opening Remarks開会挨拶

Mr. Yoshihiro HIRATA

Senior Managing Director Media Business
Nikkei Inc.

Mr.Katsunori WATANABE

Deputy mayor
City of Yokohama

9:08 - 9:20

Special Messageスペシャルメッセージ

H.E. Mr. Félix Antoine TSHISEKEDI TSHILOMBO

President of the Democratic Republic of Congo

9:20 - 9:35

Keynote Speech 1基調講演1
野口英世アフリカ賞受賞

Dr. Jean-Jacques MUYEMBE-TAMFUM

General Director of National Institute for Biomedical Research(INRB),
Professor of Microbiology, Faculty of Medicine, University of Kinshasa

9:35 - 9:50

Keynote Speech 2基調講演2
野口英世アフリカ賞受賞

Dr. Francis Gervase OMASWA

Executive Director and founder,
African Centre for Global Health and Social Transformation (ACHEST)

9:50 - 10:00

Talk sessionトークセッション

Moderator

Dr. Takao TODA Ph.D.

Vice President for Human Security and Global Health
Japan International Cooperation Agency

Dr. Jean-Jacques MUYEMBE-TAMFUM

General Director of National Institute for Biomedical Research(INRB),
Professor of Microbiology, Faculty of Medicine, University of Kinshasa

Dr. Francis Gervase OMASWA

Executive Director and founder,
African Centre for Global Health and Social Transformation (ACHEST)

10:05 - 10:15

Agenda1 - Defining the 6th Conference議題1 第6回会議の意義付け

Dr. Shigeru OMI, MD, PhD

President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific

10:15 - 11:10

Agenda2 - Progress and Perspective of TB Consortium P3 Projects議題2 結核コンソーシアムのP3プロジェクトの進捗と今後の展望

Moderator

Dr. Kazunari ASANUMA, MD, PhD

Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Kei KATSUNO, MD, MPH

    Senior Director,
    Investment Strategy & Government Relations
    Global Health Innovative Technology Fund (GHIT Fund)

  • Dr. Seiya KATO

    Director,
    Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)

  • Prof. Osamu KUNII, MD, MPH, PhD,

    Head, Strategy, Investment and Impact Division
    The Global Fund to Fight AIDS, Tuberculosis and Malaria

  • Dr. Junko SATO, PhD

    Office Director, Office of International Program
    Pharmaceuticals and Medical Devices Agency

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Mr. Ikuo TAKIZAWA

    Deputy Director General, Human Development Department,
    Japan International Cooperation Agency

  • Dr. Hiroyuki NODA, MD, PhD

    Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor
    Cabinet Secretariat

  • Mr. Mitsuru MIYATA

    Executive Leader Writer, Nikkei Business Publications, Inc.

  • Dr. Yasuhiro YASUTOMI, DVM, PhD

    Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

  • Mr. Hiroshi YOSHIDA

    Director, R&D,
    NIPRO CORPORATION

  • Mr. Hajime WATARI 

    Executive Officer, GM, Global Sales & Business Development
    EIKEN Chemical Co.,Ltd.

  • Dr. dr. Erlina BURHAN, Sp.P (K). MSc.

    Head Division of Pulmonology Infection, Department of Pulmonology, Faculty of Medicine, Universitas Indonesia.
    Member of Infectious Disease and Immunology Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia

  • Dr. Abidan CHANSA

    Consultant Physician/Member Clinical Expert Committee on TB
    Ministry of Health Zambia

  • Patricia A. DARRAH, Ph.D.

    Head, Tuberculosis Unit
    Vaccine Research Center, NIAID, NIH

  • Dr. Lucica DITIU

    Executive Director
    Stop TB Partnership

  • Mr. Celso Cachin MANANGAN

    Member, International Board, Germany PPP Initiative Group (for the Establishment of the UNECE-affiliated PPP Centre of Excellence in Sustainable Health), Frankfurt am Main, Germany
    PPP Health Advisor, SDG.17 Consulting GmBH, Frankfurt am Main, Germany
    Head, Business Development, SteraMist Philippines

  • Dr. Amit N THAKKER

    Chairman
    Africa Health Business

11:20 - 12:15

Agenda3 - Ebola Outbreaks in DRC; Emergency Usage of Unapproved Potential Medical Drugs議題3 エボラ出血熱流行~新興・再興感染症への未承認薬使用の必要性や課題を議論する

Moderator

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD

    Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

  • Tatsuo IIYAMA, M.D.

    Senior Manager, Executive Management Section, Department of International Trials, Center for Clinical Sciences,
    National Center for Global Health and Medicine (NCGM)

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Dr. Hiroyuki KATO, MD, DTM&H

    President
    MEDECINS SANS FRONTIERES JAPAN

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Mr. Ikuo TAKIZAWA

    Deputy Director General, Human Development Department,
    Japan International Cooperation Agency

  • Yasuhiro FUJIWARA, MD, PhD

    Chief Executive
    Pharmaceuticals and Medical Devices Agency

  • Takeo HOJO (Mr.)

    Managing Director
    Saraya Manufacturing (U) Ltd.
    Saraya Kenya Co., Ltd.

  • Mr. Akira YASUI

    Councillor, Director General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Responses
    Cabinet Secretariat,

  • Prof. Jiro YASUDA PhD, DVM

    Director, National Research Center for the Control and Prevention of Infectious Diseases (CCPID) &
    Professor, Institute of Tropical Medicine (NEKKEN), Nagasaki University

  • Mr. Koichi YAMADA

    Pharmaceutical Division, Manager
    FUJIFILM Corporation

  • Dr. Seth BERKLEY

    CEO
    Gavi, the Vaccine Alliance

  • Dr. Richard H. KASZYNSKI

    Senior Medical Advisor
    Democratic Republic of Congo

  • Mr. Ryan MORHARD, JD

    Lead, Global Health Security,
    World Economic Forum

  • Prof. Baron PETER PIOT MD PhD

    Director and Handa Professor of Global Health
    London School of Hygiene & Tropical Medicine

  • Dr. Amit N THAKKER

    Chairman
    Africa Health Business

12:30 - 13:30

Lunch Session - From Prevention to Treatment ---Issues in Asia and Japan's Contribution to their solutionランチセッション アジアにおける感染症の予防から治療まで~アジアの課題と日本の貢献~

Moderator

Dr. Kazuhiro TATEDA, MD, PhD

Department of Microbiology and Infectious Diseases,
Toho University School of Medicine

Click here for a list of discussers

  • Yoshikazu ISHII, Ph.D.

    Department of Microbiology and Infectious Diseases, Professor
    Toho University School of Medicine

  • Ichiro KURANE, M.D., Ph.D.

    Honorary Staff Member,
    National Institute of Infectious Diseases

13:40 - 14:35

Agenda4 - Achievements of Malaria Consortium and its Future Challenges議題4 マラリアコンソーシアムの成果と課題

Moderator

Prof. Kiyoshi KITA

Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Kei KATSUNO, MD, MPH

    Senior Director,
    Investment Strategy & Government Relations
    Global Health Innovative Technology Fund (GHIT Fund)

  • Prof. Akira KANEKO, MD, PhD, DTM&H

    Professor, Department of Parasitology,
    Osaka City University Graduate School of Medicine

  • Dr. Shigeyuki KANO, MD, PhD,Hon PhD (Mahidol)

    Director, Department of Tropical Medicine and Malaria,
    Research Institute,National Center for Global Health and Medicine (NCGM)

  • Mr. Osamu SAKURAI (MPhil) 

    Risk Advisory, Public Sector/Manager
    Deloitte Touche Tohmatsu LLC

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Prof. Dr. Tomohiko SUGISHITA

    Department of International Affairs and Tropical Medicine
    Tokyo Women’s Medical University

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Mr. Ray NISHIMOTO

    Executive Vice President
    Sumitomo Chemical Company, Ltd.

  • Dr. Hiroyuki NODA, MD, PhD

    Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor
    Cabinet Secretariat

  • Mr.Yutaka HADA

    Public Affairs Department, Manager
    Toyota Tsusho Corporation

  • Mr. Yoshihide HIRUTA

    Director of International Cooperation, International Business Management, Global Support
    Sysmex Corporation

  • Mr. Mitsuru MIYATA

    Executive Leader Writer, Nikkei Business Publications, Inc.

  • Dr. Yasuyoshi MORI, PhD

    Biochemical Research Laboratory II / General Manager
    Eiken Chemical Co.,Ltd.

  • Dr. John NKENGASONG MSc, PHD

    Director
    Africa Centers for Disease Control and Prevention (CDC)- African Union Commission

  • Assoc. Prof. Pratap SINGHASIVANON,
    MBBS, DTM & H, MPH, DrPH

    Dean, Faculty of Tropical Medicine
    Mahidol University

  • Dr. Amit N THAKKER

    Chairman
    Africa Health Business

14:45 - 15:40

Agenda5 - Global PPP against the Risks of AMR; Challenges towards the Next Step議題5 拡大する薬剤耐性(AMR)のリスクに対するグローバルな産官学連携の課題と次のステップ

Moderator

Mr. Yasuhide YAMADA

Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat,Government of Japan
Executive Officer, SHIMIZU CORPORATION

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD

    Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

  • Hajime INOUE, MD, MPH, DrPH

    Director General, Bureau of Strategic Planning
    National Center for Global Health and Medicine(NCGM)

  • Prof. Kazumasa OGURO

    Professor
    Hosei University 

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Dr. Junko SATO, PhD

    Office Director, Office of International Program
    Pharmaceuticals and Medical Devices Agency

  • Ms. Takuko SAWADA

    Director of the Board, Executive Vice President
    Shionogi & Co., Ltd.

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Dr. Kensuke SHOJI , MD, PhD

    Division Chief
    National Center for Child Health and Development

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Dr. Kazuhiro TATEDA, MD, PhD

    Department of Microbiology and Infectious Diseases,
    Toho University School of Medicine

  • Yasunori TAWARAGI, PhD

    Director, International Affairs
    Japan Pharmaceutical Manufacturers Association

  • Mr. Ryoji NORITAKE

    CEO and Board Member, Health and Global Policy Institute (HGPI)

  • Director. Dr. Hideaki HANAKI, Ph, PhD

    Director, Infection Control Research Center, Kitasato University

  • Dr. Kazuki HOSHINO, PhD

    Technology Department, Vice President
    Daiichi Sankyo Biotech Co., Ltd.

  • Prof. Satoshi MITARAI MD, Ph.D.

    Head, Dept. of Mycobacterium Reference and Research
    Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association

  • Mr. Mitsuru MIYATA

    Executive Leader Writer, Nikkei Business Publications, Inc.

  • Takeo MOROOKA, MD, MPH

    Executive Officer, Head of Health Policy and Corporate Support
    MSD K.K.

  • Mr. Thomas B. CUENI

    Director General
    International Federation of Pharmaceutical Manufacturers & Associations

  • Mr. Ryan MORHARD, JD

    Lead, Global Health Security,
    World Economic Forum

  • Dr. Jean-Pierre PACCAUD, PhD

    Director of Business Development and Corporate Strategy
    Global Antibiotic R&D Partnership Foundation (GARDP)

16:00 - 16:50 Breakout Session A-1分科会 A-1 Breakout Session B-1分科会 B-1

A-1 MSD/SHIONOGI

Efforts to realize the sustainable development and access of novel treatments for AMR持続可能な新規AMR治療薬等の開発とアクセスを実現する取り組み

Moderator

Toshinobu SATO, MD, PhD

Professor of President’s Office
Kurume University

Click here for a list of discussers

  • Visiting Professor
    Osamu UTSUNOMIYA , MD, MPH, PhD

    School of Medicine, Visiting Professor
    Keio University

  • Prof. Kazumasa OGURO

    Professor
    Hosei University 

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Dr. Kazuhiro TATEDA, MD, PhD

    Department of Microbiology and Infectious Diseases,
    Toho University School of Medicine

  • Yasunori TAWARAGI, PhD

    Director, International Affairs
    Japan Pharmaceutical Manufacturers Association

  • Shoji MIYAGAWA, DVM.MS

    Director, Division of Infectious Disease Research
    the Japan Agency for Medical Research and Development

  • Dr. Yoshinori YAMANO, Ph.D.

    Chief Scientific Officer for Infectious Diseases,
    Pharmaceutical Research Division,
    SHIONOGI & CO., LTD.

  • Dr. Jean-Pierre PACCAUD, PhD

    Director of Business Development and Corporate Strategy
    Global Antibiotic R&D Partnership Foundation (GARDP)

  • Mr. Paul SCHAPER, MPH, MA, MBA

    Executive Director, Global Public Policy
    MSD

B-1 FUJIFILM Toyama Chemical

Current landscape and future prospects of antiviral treatment for SFTS (severe fever with thrombocytopenia syndrome) SFTS抗ウイルス剤治療の現状と課題

Moderator

Prof. Nikki SHINDO, MD, PhD

Senior Advisor,
WHO’s Health Emergency Programme (WHE), World Health Organization

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD

    Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

  • Masayuki SAIJO , MD, PhD

    Director, Department of Virology 1,
    National Institute of Infectious Diseases

  • Dr. Junko SATO, PhD

    Office Director, Office of International Program
    Pharmaceuticals and Medical Devices Agency

  • Prof. Dr. Masaki YASUKAWA, MD, PhD

    Professor, Proteo-Science Center
    Ehime University

  • Mr. Koichi YAMADA

    Pharmaceutical Division, Manager
    FUJIFILM Corporation

Breakout Session C-1分科会 C-1 Breakout Session D-1分科会 D-1

C-1 Sumitomo Chemical

Japan's Initiatives for Malaria Elimination in Africaアフリカにおけるマラリアeliminationに向けた日本の取り組み

Moderator

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Prof. Akira KANEKO, MD, PhD, DTM&H

    Professor, Department of Parasitology,
    Osaka City University Graduate School of Medicine

  • Mr. Ray NISHIMOTO

    Executive Vice President
    Sumitomo Chemical Company, Ltd.

  • Mr. Tatsuo MIZUNO

    Board Member
    Malaria No More Japan

  • Prof. Noboru MINAKAWA Ph.D.

    Professor, Institute of Tropical Medicine, Nagasaki University

D-1 Saraya

Jigger Infestation in Africa Sub Sahara Regions; Current Situation and Challengesアフリカにおけるスナノミ被害の現状と対策

Moderator

Mr. Michikazu KOSHIBA

Head, Center on Global Health Architecture/
General Manager, Social Impact Partnership Business Dept.
MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

Click here for a list of discussers

  • Mr. Kozo AKINO

    Member of the House of Councilors

  • Prof. Satoshi KANEKO, MD,MPH, PhD

    Professor
    Institute of Tropical Medicine, Nagasaki University

  • Ms. Noriko SHIRASU

    Executive Director
    RESULTS Japan

  • Takeo HOJO (Mr.)

    Managing Director
    Saraya Manufacturing (U) Ltd.
    Saraya Kenya Co., Ltd.

17:00 - 17:50 Breakout Session A-2分科会 A-2 Breakout Session B-2分科会 B-2

A-2 MSD/SHIONOGI

Efforts to realize the sustainable development and access of novel treatments for AMR持続可能な新規AMR治療薬等の開発とアクセスを実現する取り組み

Moderator

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Prof. Kazumasa OGURO

    Professor
    Hosei University 

  • Toshinobu SATO, MD, PhD

    Professor of President’s Office
    Kurume University

  • Dr. Satoshi SHIMADA, MD, MTM, PhD

    Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer
    Ministry of Health, Labour and Welfare

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Dr. Kazuhiro TATEDA, MD, PhD

    Department of Microbiology and Infectious Diseases,
    Toho University School of Medicine

  • Yasunori TAWARAGI, PhD

    Director, International Affairs
    Japan Pharmaceutical Manufacturers Association

  • Shoji MIYAGAWA, DVM.MS

    Director, Division of Infectious Disease Research
    the Japan Agency for Medical Research and Development

  • Dr. Yoshinori YAMANO, Ph.D.

    Chief Scientific Officer for Infectious Diseases,
    Pharmaceutical Research Division,
    SHIONOGI & CO., LTD.

  • Dr. Jean-Pierre PACCAUD, PhD

    Director of Business Development and Corporate Strategy
    Global Antibiotic R&D Partnership Foundation (GARDP)

  • Mr. Paul SCHAPER, MPH, MA, MBA

    Executive Director, Global Public Policy
    MSD

B-2 DAIICHI SANKYO

Vaccine hesitancy: A global threat to fighting against infectious diseases, which can be prevented by vaccines「予防接種への躊躇」~ ワクチンで予防可能な感染症の制御を脅かすグローバル課題 ~

Moderator

Dr. Norihito UEDA, MD, PhD

Senior Medical Director, Biologics Planning Department, Biologics Division
DAIICHI SANKYO CO., LTD.

Click here for a list of discussers

  • Dr. Nobuhiko OKABE, MD, Ph.D.

    Director General,
    Kawasaki City Institute for Public Health

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Shuichiro HAYASHI, MD, MPH

    Director,Immunization Office, Health Service Division, Health Service Bureau
    Ministry of Health, Labour and Welfare

  • Mr. Hisahiko YANO

    Senior Staff Writer Editional Bureau
    Nikkei Inc.

  • Mr. Thomas B. CUENI

    Director General
    International Federation of Pharmaceutical Manufacturers & Associations

  • Dr. Gary DUBIN, MD

    Senior Vice President and Head, Global Medical Office, Vaccine Business Unit
    Takeda Pharmaceuticals Company Limited

  • Dr. Jean-Jacques MUYEMBE-TAMFUM

    General Director of National Institute for Biomedical Research(INRB),
    Professor of Microbiology, Faculty of Medicine, University of Kinshasa

Breakout Session C-2分科会 C-2 Breakout Session D-2分科会 D-2

C-2 SYSMEX

Malaria-free Continent: Africa and Japan working together for sustainable growthマラリアのない大陸へ:持続的な成長に向けた日本・アフリカの協働

Moderator

Prof. Dr. Tomohiko SUGISHITA

Department of International Affairs and Tropical Medicine
Tokyo Women’s Medical University

Click here for a list of discussers

  • Prof. Theresa L COETZER, PhD

    Research Professor
    Wits Research Institute for Malaria
    Department of Molecular Medicine and Haematology
    University of the Witwatersrand

  • Ms. Samantha GIANGREGORIO

    Managing Director, Essential Health Care,
    Sysmex EMEA (Europe, Middle East and Africa)

  • Dr. Francis Gervase OMASWA

    Executive Director and founder,
    African Centre for Global Health and Social Transformation (ACHEST)

  • Mr. Eric OSEI

    MANAGING DIRECTOR
    Sysmex West and Central Africa Ltd

  • Dr. Amit N THAKKER

    Chairman
    Africa Health Business

D-2 FUMAKILLA

Development of Mosquito Killer Products in Asia and Its Application to Malaria Control in Africaアジアにおける蚊殺虫剤製品の展開と、アフリカのマラリア対策への応用について

Moderator

Prof. Noboru MINAKAWA Ph.D.

Professor, Institute of Tropical Medicine, Nagasaki University

Click here for a list of discussers

  • Hajime INOUE, MD, MPH, DrPH

    Director General, Bureau of Strategic Planning
    National Center for Global Health and Medicine(NCGM)

  • Dr. Hitoshi KAWADA

    Institute of Tropical Medicine / Associate Professor
    Nagasaki University

  • Mr. Tatsuo MIZUNO

    Board Member
    Malaria No More Japan

  • Mr. Toshiaki MURAMOTO

    Director, International planning department manager and in charge of Fumakilla Vietnam operation
    Fumakilla Limited

18:00 - 18:45

Special Session - Improving outcomes through public-private partnerships in health: achievements and challenges特別セッション 産官学連携で感染症対策を前進させる:成果と課題

Moderator

Mr. Andrew JACK

Global education editor
Financial Times

Click here for a list of discussers

  • Dr. Kiyoshi KUROKAWA

    Chair, Hideyo Noguchi Africa Prize Committee
    Chair of the Board, Health and Global Policy Institute
    Professor Emeritus, National Graduate Institute for Policy Studies and the University of Tokyo

  • Dr. Yasuhiro SUZUKI

    Vice-Minister for Health/Chief Medical & Global Health Officer
    Ministry of Health,
    Labor & Welfare

  • Dr. Seth BERKLEY

    CEO
    Gavi, the Vaccine Alliance

  • Prof. Baron PETER PIOT MD PhD

    Director and Handa Professor of Global Health
    London School of Hygiene & Tropical Medicine

DAY2September 1(SUN.) 9月1日(日)

* Please note that program details may be subject to change.
* Simultaneous interpretation is available at this conference.

8:30 -

Doors open開場

9:00 - 9:15

Special Speech 1特別講演1

Mr. Thomas B. CUENI

Director General
International Federation of Pharmaceutical Manufacturers & Associations

9:15 - 9:40

Special Speech 2特別講演2

Moderator

Mr. Ryoji NORITAKE

CEO and Board Member, Health and Global Policy Institute (HGPI)

Click here for a list of discussers

  • Mr. Masahiko KIYA

    Deputy Assistant Minister,Ambassador for TICAD
    African Affairs Department, International Cooperation Bureau
    Ministry of Foreign Affairs

  • Dr. Seth BERKLEY

    CEO
    Gavi, the Vaccine Alliance

9:40 - 11:10

Agenda6 - Establishment of Clinical Research Platform in Asia and Africa議題6 アジア・アフリカにおける感染症臨床試験プラットフォームの構築について

Moderator

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Tatsuo IIYAMA, M.D.

    Senior Manager, Executive Management Section, Department of International Trials, Center for Clinical Sciences,
    National Center for Global Health and Medicine (NCGM)

  • Hajime INOUE, MD, MPH, DrPH

    Director General, Bureau of Strategic Planning
    National Center for Global Health and Medicine(NCGM)

  • Dr. Hayato URABE, PhD, MPIA

    Senior Director, Investment Strategy and Management
    Global Health Innovative Technology Fund

  • Prof. Hitoshi OSHITANI, MD, PhD, MPH

    Professor, Department of Virology
    Tohoku University Graduate School of Medicine

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Dr. Shigeyuki KANO, MD, PhD,Hon PhD (Mahidol)

    Director, Department of Tropical Medicine and Malaria,
    Research Institute,National Center for Global Health and Medicine (NCGM)

  • Mr. Taiichiro KAMIYA

    President
    Nomura Siam International Co., Ltd.

  • Prof. Kiyoshi KITA

    Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

  • Dr. Tatsuya KONDO

    Chief Executive Officer
    Medical Excellence JAPAN 

  • Ms. Akiko SAKAUE

    Global Health Consultant
    United Nations Development Programme (UNDP), Representation Office in Tokyo

  • Yasuyuki SAHARA, MD, MPH

    Senior Assistant Minister for Global Health
    Ministry of Health, Labour and Welfare

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Dr. Akiko TANAKA

    Director, International Infection Diseases Control Office,
    Ministry of Health, Labour and Welfare

  • Dr. Hiroyuki NODA, MD, PhD

    Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor
    Cabinet Secretariat

  • Prof. Jiro FUJITA, MD, PhD, FCCP

    Professor,
    University of the Ryukyus Hospital

  • Mr. Kazuhiko MORI

    Councilor for Pharamaceutical Affairs, Minister’s Secretariat
    Ministry of Health, Labour and Welfare

  • Dr. Yasuhiro YASUTOMI, DVM, PhD

    Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

  • Dr. dr. Erlina BURHAN, Sp.P (K). MSc.

    Head Division of Pulmonology Infection, Department of Pulmonology, Faculty of Medicine, Universitas Indonesia.
    Member of Infectious Disease and Immunology Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia

  • Patricia A. DARRAH, Ph.D.

    Head, Tuberculosis Unit
    Vaccine Research Center, NIAID, NIH

  • Prof. Dr. Suchinda MALAIVIJITNOND, Ph.D.

    Professor at Chulalongkorn University, and Director of the National Primate Research Center of Thailand
    Chulalongkorn University (NPRCT-CU)

  • Dr. John NKENGASONG MSc, PHD

    Director
    Africa Centers for Disease Control and Prevention (CDC)- African Union Commission

  • Assoc. Prof. Pratap SINGHASIVANON,
    MBBS, DTM & H, MPH, DrPH

    Dean, Faculty of Tropical Medicine
    Mahidol University

  • Dr. Amit N THAKKER

    Chairman
    Africa Health Business

11:20 - 12:15

Agenda7 - Future of Technology: Where should we go toward?議題7 テクノロジーの未来:我々はどこに向かうべきか?

Moderator①

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Moderator②

Mr. Michikazu KOSHIBA

Head, Center on Global Health Architecture/
General Manager, Social Impact Partnership Business Dept.
MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

Click here for a list of discussers

  • Dr. Hayato URABE, PhD, MPIA

    Senior Director, Investment Strategy and Management
    Global Health Innovative Technology Fund

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Prof. Osamu KUNII, MD, MPH, PhD,

    Head, Strategy, Investment and Impact Division
    The Global Fund to Fight AIDS, Tuberculosis and Malaria

  • Dr. Tatsuya KONDO

    Chief Executive Officer
    Medical Excellence JAPAN 

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Dr. Akiko TANAKA

    Director, International Infection Diseases Control Office,
    Ministry of Health, Labour and Welfare

  • Mr. Susumu TSUBAKI

    Representative Director/CEO
    Asia Africa Investment and Consulting Pte. Ltd.(AAIC)

  • Mr. Motoyasu TOKUNAGA

    Executive Officer&General Manager SystemSolution Department
    HORIZON Inc.

  • Prof. Hiroshi NISHIURA, M.D., Ph.D.

    Professor, Graduate School of Medicine
    Hokkaido University

  • Kuniaki MIYAKE MD,MSc

    CMO
    DeNA

  • Eiichi YOSHIDA,DDS

    President and CEO
    E-TECH Co.,Ltd

  • Dr. Lucica DITIU

    Executive Director
    Stop TB Partnership

  • Dr. Gary DUBIN, MD

    Senior Vice President and Head, Global Medical Office, Vaccine Business Unit
    Takeda Pharmaceuticals Company Limited

  • Dr. Kagiso NDLOVU

    eHealth Research Unit Coordinator
    University of Botswana

  • Mr. Dykki SETTLE

    Chief Digital Officer,
    Director, Center of Digital and Data Excellence,
    Board Chair, Digital Square
    PATH

  • Mr. Moz SIDDIQUI

    Senior Manager,
    Strategic Innovation and Partnerships at Gavi,
    the Vaccine Alliance

12:30 - 13:30

Lunch Session - Innovative Development of Pandemic Influenza Control Strategyランチセッション 新型インフルエンザ対策の新たな展開

Moderator

Mr. Mitsuru MIYATA

Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Nobuhiko OKABE, MD, Ph.D.

    Director General,
    Kawasaki City Institute for Public Health

  • Dr. Kenji SHUTO

    Vice Governor
    Kanagawa Prefecture 

  • Natsuo TACHIKAWA, MD

    Director
    Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital

  • Dr. Hiroyuki NODA, MD, PhD

    Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor
    Cabinet Secretariat

  • Yoshihide HAYASHIZAKI, MD, PhD

    Preventive Medicine and Diagnosis Innovation Program
    Program Director
    RIKEN

  • Seigo HARA,MD

    CEO 
    MICIN Inc. 

13:40 - 14:55

Agenda8 - UHC and Communicable Diseases: Tradition and Innovation議題8 UHCから感染症対策を考える:伝統と革新

Moderator

Mr. Michikazu KOSHIBA

Head, Center on Global Health Architecture/General Manager, Social Impact Partnership Business Dept.
MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

Click here for a list of discussers

  • Mr. Tsunenori AOKI

    Director, Health Team 1, Human Development Department
    JICA

  • Dr. Shigeru OMI, MD, PhD

    President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
    World Health Organization (WHO), Regional Office for Western Pacific

  • Ms. Mihoko KASHIWAKURA

    Head of Japan Relations
    Bill and Melinda Gates Foundation

  • Mr. Yosuke KANEKO

    Chief Strategy Officer
    Terra Drone Corporation

  • Ms. Akiko SAKAUE

    Global Health Consultant
    United Nations Development Programme (UNDP), Representation Office in Tokyo

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Dr. Yoko SHIMPUKU, PhD, CNM, RN

    Human Health Sciences, Family Nursing, Maternal Nursing/Midwifery, Associate Professor
    Kyoto University, Graduate School of Medicine

  • Prof. Dr. Tomohiko SUGISHITA

    Department of International Affairs and Tropical Medicine
    Tokyo Women’s Medical University

  • Manabu SUMI, MD, MPH, PhD

    Director, Global Health Policy Division,
    Ministry of Foreign Affairs

  • Dr. Takao TODA Ph.D.

    Vice President for Human Security and Global Health
    Japan International Cooperation Agency

  • Naofumi HASHIMOTO (Mr),MLT.MSc

    Division of Partnership Development, Department of Global Network and Partnership, Bureau of International Health Cooperation(BIHC)
    National Center for Global Health and Medicine(NCGM)

  • Mr. Shigeru HANDA

    Director
    Asia Africa Investment and Consulting Pte. Ltd.

  • Mr. Motoki WATANABE

    International Cooperation Group, Group Manager
    Yamaha Motor Co., Ltd.

  • Ms. Maraki Fikre MERID, PhD, MPH

    Consultant for Private Sector in Health,
    CHS Advisory,
    The World Bank Group/ MoH Ethiopia

  • Dr. John NKENGASONG MSc, PHD

    Director
    Africa Centers for Disease Control and Prevention (CDC)- African Union Commission

  • Mr. Dykki SETTLE

    Chief Digital Officer,
    Director, Center of Digital and Data Excellence,
    Board Chair, Digital Square
    PATH

  • Ms. Marie STAUNTON, CBE

    Chair - Crown Agents Board
    Crown Agents

  • Prof. Yves TRAORE

    Managing Director
    Sysmex Partec Burkina Faso SARL

15:05 - 16:00

Summary Sessionサマリーセッション

Moderator

Dr. Shigeru OMI, MD, PhD

President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
World Health Organization (WHO), Regional Office for Western Pacific

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD

    Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

  • Dr. Norihito UEDA, MD, PhD

    Senior Medical Director, Biologics Planning Department,  Biologics Division
    DAIICHI SANKYO CO., LTD.

  • Prof. Kiyoshi KITA

    Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

  • Mr. Michikazu KOSHIBA

    Head, Center on Global Health Architecture/
    General Manager, Social Impact Partnership Business Dept.
    MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Prof. Dr. Tomohiko SUGISHITA

    Department of International Affairs and Tropical Medicine
    Tokyo Women’s Medical University

  • Dr. Kazuhiro TATEDA, MD, PhD

    Department of Microbiology and Infectious Diseases,
    Toho University School of Medicine

  • Prof. Noboru MINAKAWA Ph.D.

    Professor, Institute of Tropical Medicine, Nagasaki University

  • Mr. Mitsuru MIYATA

    Executive Leader Writer, Nikkei Business Publications, Inc.

  • Dr. Yasuhiro YASUTOMI, DVM, PhD

    Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

16:10 - 16:40

Conclusion/Statementステートメント策定

Moderator

Dr. Shigeru OMI, MD, PhD

President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD

    Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare

  • Dr. Norihito UEDA, MD, PhD

    Senior Medical Director, Biologics Planning Department,  Biologics Division
    DAIICHI SANKYO CO., LTD.

  • Prof. Kiyoshi KITA

    Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

  • Mr. Michikazu KOSHIBA

    Head, Center on Global Health Architecture/
    General Manager, Social Impact Partnership Business Dept.
    MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

  • Prof. Nikki SHINDO, MD, PhD

    Senior Advisor,
    WHO’s Health Emergency Programme (WHE), World Health Organization

  • Prof. Dr. Tomohiko SUGISHITA

    Department of International Affairs and Tropical Medicine
    Tokyo Women’s Medical University

  • Dr. Kazuhiro TATEDA, MD, PhD

    Department of Microbiology and Infectious Diseases,
    Toho University School of Medicine

  • Prof. Noboru MINAKAWA Ph.D.

    Professor, Institute of Tropical Medicine, Nagasaki University

  • Mr. Mitsuru MIYATA

    Executive Leader Writer, Nikkei Business Publications, Inc.

  • Dr. Yasuhiro YASUTOMI, DVM, PhD

    Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

16:40 - 16:50

General Overview総評

Prof. Keizo TAKEMI

Member of the House of Councillors,
Deputy Chairperson of General Council, LDP
Chairman of Special Committee on Global Health Strategy of LDP
Senior Fellow, Japan Center for International Exchange (JCIE)
Visiting Professor at Nagasaki University

お申し込み受付を終了しました

topへ戻る